These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6162063)

  • 21. Development of aggressive squamous cell carcinoma in epidermodysplasia verruciformis associated with human papillomavirus type 22b.
    Kim T; Park JC; Roh MR; Park JM; Kim SH; Cho NH; Lee MG
    Dermatology; 2010; 220(4):326-8. PubMed ID: 20460877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermodysplasia verruciformis and human papilloma virus.
    Gewirtzman A; Bartlett B; Tyring S
    Curr Opin Infect Dis; 2008 Apr; 21(2):141-6. PubMed ID: 18317036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Papillomaviruses and skin cancer in Africa.
    Lutzner MA
    IARC Sci Publ; 1984; (63):607-23. PubMed ID: 6100284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of epidermodysplasia verruciformis with squamous cell carcinomas on non-sun-exposed areas of skin.
    Ansarin H; Tajziehchi L; Shaianfar N
    Arch Iran Med; 2007 Apr; 10(2):261-3. PubMed ID: 17367237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the etiology and pathogenesis of epidermodysplasia verruciformis Lewandowski--Lutz.
    Jablońska S; Biczysko W; Langner A; Jakubowicz K; Dabrowski J
    Pol Med J; 1970; 9(2):491-8. PubMed ID: 4192930
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis.
    Orth G; Jablonska S; Favre M; Croissant O; Jarzabek-Chorzelska M; Rzesa G
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1537-41. PubMed ID: 206906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermodysplasia verruciformis. Skin carcinoma containing human papillomavirus type 5 DNA sequences and primary hepatocellular carcinoma associated with chronic hepatitis B virus infection in a patient.
    van Voorst Vader PC; Orth G; Dutronquay V; Driessen LH; Eggink HF; Kallenberg CG; The TH
    Acta Derm Venereol; 1986; 66(3):231-6. PubMed ID: 2426900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Merkel cell polyomavirus in epidermodysplasia-verruciformis-associated skin neoplasms.
    Mertz KD; Schmid M; Burger B; Itin P; Palmedo G; Schärer L; Kutzner H; Fernández Figueras MT; Cribier B; Pfaltz M; Kempf W
    Dermatology; 2011 Feb; 222(1):87-92. PubMed ID: 21099200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An epidermoid carcinoma case developed on old surgical scar in an epidermodysplasia verruciformis patient.
    Ozyazgan I; Kontas O; Gokahmetoglu S; Ozkul Y
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):640-2. PubMed ID: 16164729
    [No Abstract]   [Full Text] [Related]  

  • 30. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin.
    Majewski S; Jabłońska S
    Arch Dermatol; 1995 Nov; 131(11):1312-8. PubMed ID: 7503577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin infections.
    Brigden D
    Br Med Bull; 1985 Oct; 41(4):357-60. PubMed ID: 2413950
    [No Abstract]   [Full Text] [Related]  

  • 32. [Epidermodysplasia verruciformis with bowenoid degeneration and multiple basocellular and spinocellular epitheliomas].
    Depaoli M
    G Ital Dermatol Minerva Dermatol; 1971 Sep; 46(9):407-17. PubMed ID: 5110064
    [No Abstract]   [Full Text] [Related]  

  • 33. The heterogeneity of tumours associated with epidermodysplasia verruciformis.
    Sandbank M; Hodak E; Rotem A; Ben-David E
    Acta Derm Venereol; 1987; 67(1):79-82. PubMed ID: 2436421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical use of interferons.
    Ringenberg QS; Anderson PC
    Int J Dermatol; 1986 Jun; 25(5):294. PubMed ID: 2424850
    [No Abstract]   [Full Text] [Related]  

  • 35. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA.
    Weissenborn SJ; Höpfl R; Weber F; Smola H; Pfister HJ; Fuchs PG
    J Invest Dermatol; 1999 Jul; 113(1):122-6. PubMed ID: 10417630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis.
    Padlewska K; Ramoz N; Cassonnet P; Riou G; Barrois M; Majewski S; Croissant O; Jablonska S; Orth G
    J Invest Dermatol; 2001 Oct; 117(4):935-42. PubMed ID: 11676835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical aspects and therapy of frequent viral diseases of the skin].
    Kölzsch J
    Z Arztl Fortbild (Jena); 1990; 84(23):1199-202. PubMed ID: 1964754
    [No Abstract]   [Full Text] [Related]  

  • 38. Warts and cancer: the oncogenic potential of human papilloma virus.
    Lynch PJ
    Am J Dermatopathol; 1982 Feb; 4(1):55-60. PubMed ID: 6282149
    [No Abstract]   [Full Text] [Related]  

  • 39. Malignant degeneration of skin lesions in epidermodysplasia verruciformis.
    Ruiter M
    Acta Derm Venereol; 1969; 49(3):309-13. PubMed ID: 4184278
    [No Abstract]   [Full Text] [Related]  

  • 40. Application of human leucocyte interferon in patients with tumours of the head and neck.
    Ikić D; Padovan I; Brodarec I; Knezević M; Soos E
    Lancet; 1981 May; 1(8228):1025-7. PubMed ID: 6164884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.